Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review
mediaposted on 2021-10-20, 09:37 authored by Adis journalson behalf of, Andrew M Blumenfeld, Benjamin M Frishberg, Jack D Schim, Ashley Iannone, Gary Schneider, Larisa Yedigarova, Aubrey Manack Adams
Article full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.